PL4200280T3 - Pochodne fenylo-3,4-dihydroizochinolin-2(1h)-ylo-etan-1-onu jako dodatnie modulatory allosteryczne receptora dopaminy d1 - Google Patents
Pochodne fenylo-3,4-dihydroizochinolin-2(1h)-ylo-etan-1-onu jako dodatnie modulatory allosteryczne receptora dopaminy d1Info
- Publication number
- PL4200280T3 PL4200280T3 PL21802476.8T PL21802476T PL4200280T3 PL 4200280 T3 PL4200280 T3 PL 4200280T3 PL 21802476 T PL21802476 T PL 21802476T PL 4200280 T3 PL4200280 T3 PL 4200280T3
- Authority
- PL
- Poland
- Prior art keywords
- dihydroisoquinolin
- ethan
- dopamine
- phenyl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063088479P | 2020-10-07 | 2020-10-07 | |
| PCT/US2021/053578 WO2022076418A1 (en) | 2020-10-07 | 2021-10-05 | Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1 receptor positive allosteric modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4200280T3 true PL4200280T3 (pl) | 2024-05-20 |
Family
ID=78516911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21802476.8T PL4200280T3 (pl) | 2020-10-07 | 2021-10-05 | Pochodne fenylo-3,4-dihydroizochinolin-2(1h)-ylo-etan-1-onu jako dodatnie modulatory allosteryczne receptora dopaminy d1 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12503442B2 (pl) |
| EP (1) | EP4200280B1 (pl) |
| JP (1) | JP7591138B2 (pl) |
| CN (1) | CN116601146A (pl) |
| DK (1) | DK4200280T3 (pl) |
| ES (1) | ES2976784T3 (pl) |
| FI (1) | FI4200280T3 (pl) |
| HR (1) | HRP20240466T1 (pl) |
| HU (1) | HUE066426T2 (pl) |
| LT (1) | LT4200280T (pl) |
| MA (1) | MA60976B1 (pl) |
| MD (1) | MD4200280T2 (pl) |
| PL (1) | PL4200280T3 (pl) |
| PT (1) | PT4200280T (pl) |
| RS (1) | RS65365B1 (pl) |
| SI (1) | SI4200280T1 (pl) |
| WO (1) | WO2022076418A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116601146A (zh) | 2020-10-07 | 2023-08-15 | 伊莱利利公司 | 作为多巴胺d1受体正变构调节剂的苯基-3,4-二氢异喹啉-2(1h)-基-乙-1-酮衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054044A1 (es) * | 2005-05-23 | 2007-05-30 | Astrazeneca Ab | Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad. |
| FR2999183A1 (fr) | 2012-12-12 | 2014-06-13 | Diverchim | Composes cyclopropyl boroniques, procede de preparation desdits composes, et leur utilisation |
| JO3316B1 (ar) * | 2013-05-30 | 2019-03-13 | Lilly Co Eli | مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل |
| ES2973289T3 (es) | 2014-09-04 | 2024-06-19 | Lobsor Pharmaceuticals Ab | Composiciones farmacéuticas en gel que comprenden levodopa, carbidopa y entacapona |
| DK3204359T3 (da) | 2014-10-08 | 2020-09-14 | UCB Biopharma SRL | Tetrahydroisoquinolinderivater |
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
| PT3897578T (pt) * | 2018-12-18 | 2025-01-13 | Lilly Co Eli | Regimes de dosagem para utilização de ly3154207 no tratamento de distúrbios do snc dopaminérgicos |
| TWI825323B (zh) | 2019-06-18 | 2023-12-11 | 美商美國禮來大藥廠 | 用於製備2-(2,6-二氯苯基)-1-[(1s,3r)-3-(羥甲基)-5-(3-羥基-3-甲基丁基)-1-甲基-3,4-二氫異喹啉-2(1h)-基]乙烯酮之方法及中間物 |
| MA56440A (fr) | 2019-07-01 | 2022-05-11 | UCB Biopharma SRL | Dérivé de tétrahydroisoquinoléine substitué utilisé en tant que modulateur allostérique positif d1 |
| CA3139622A1 (en) | 2019-07-01 | 2021-01-07 | UCB Biopharma SRL | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator |
| CN116601146A (zh) | 2020-10-07 | 2023-08-15 | 伊莱利利公司 | 作为多巴胺d1受体正变构调节剂的苯基-3,4-二氢异喹啉-2(1h)-基-乙-1-酮衍生物 |
| AU2022234744B2 (en) | 2021-03-08 | 2025-06-26 | Eli Lilly And Company | Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis |
| US20240165101A1 (en) | 2021-03-09 | 2024-05-23 | Eli Lilly And Company | Use of mevidalen and other d1 positive allosteric modulators for slowing of parkinson's disease progression |
-
2021
- 2021-10-05 CN CN202180077762.XA patent/CN116601146A/zh active Pending
- 2021-10-05 LT LTEPPCT/US2021/053578T patent/LT4200280T/lt unknown
- 2021-10-05 HU HUE21802476A patent/HUE066426T2/hu unknown
- 2021-10-05 HR HRP20240466TT patent/HRP20240466T1/hr unknown
- 2021-10-05 SI SI202130120T patent/SI4200280T1/sl unknown
- 2021-10-05 MA MA60976A patent/MA60976B1/fr unknown
- 2021-10-05 JP JP2023521348A patent/JP7591138B2/ja active Active
- 2021-10-05 WO PCT/US2021/053578 patent/WO2022076418A1/en not_active Ceased
- 2021-10-05 MD MDE20230653T patent/MD4200280T2/ro unknown
- 2021-10-05 FI FIEP21802476.8T patent/FI4200280T3/fi active
- 2021-10-05 DK DK21802476.8T patent/DK4200280T3/da active
- 2021-10-05 PT PT218024768T patent/PT4200280T/pt unknown
- 2021-10-05 ES ES21802476T patent/ES2976784T3/es active Active
- 2021-10-05 PL PL21802476.8T patent/PL4200280T3/pl unknown
- 2021-10-05 US US18/030,853 patent/US12503442B2/en active Active
- 2021-10-05 RS RS20240398A patent/RS65365B1/sr unknown
- 2021-10-05 EP EP21802476.8A patent/EP4200280B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT4200280T (pt) | 2024-03-26 |
| MA60976B1 (fr) | 2024-05-31 |
| ES2976784T3 (es) | 2024-08-08 |
| EP4200280A1 (en) | 2023-06-28 |
| SI4200280T1 (sl) | 2024-04-30 |
| HRP20240466T1 (hr) | 2024-07-05 |
| WO2022076418A1 (en) | 2022-04-14 |
| JP2023545060A (ja) | 2023-10-26 |
| HUE066426T2 (hu) | 2024-08-28 |
| CN116601146A (zh) | 2023-08-15 |
| JP7591138B2 (ja) | 2024-11-27 |
| RS65365B1 (sr) | 2024-04-30 |
| DK4200280T3 (da) | 2024-03-04 |
| FI4200280T3 (fi) | 2024-05-03 |
| LT4200280T (lt) | 2024-04-25 |
| MD4200280T2 (ro) | 2024-08-31 |
| US20230382869A1 (en) | 2023-11-30 |
| EP4200280B1 (en) | 2024-02-21 |
| US12503442B2 (en) | 2025-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2490692A4 (en) | CHINOLINONE PYRAZOLON M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | |
| ZA202102263B (en) | Oral formulations of kappa opioid receptor agonists | |
| WO2009100294A3 (en) | Amide derivatives as positive allosteric modulators and methods of use thereof | |
| EP2331534A4 (en) | BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGUES AS MODULATORS OF SIRTUINE | |
| IL213630A0 (en) | Oxadiazole derivatives as slpl receptor agonists | |
| ZA201204313B (en) | Quinoline amide m1 receptor positive allosteric modulators | |
| GB2460597B8 (en) | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors | |
| MA55046A (fr) | Utilisation de dérivés d'indole n-substitués comme modulateurs des récepteurs des pge2 | |
| IL272017A (en) | Positive allosteric modulators of muscarinic m2 receptor | |
| SI2176220T1 (sl) | Pirolidin-2-onski derivati kot modulatorji androgenskih receptorjev | |
| EP2445891A4 (en) | 5-CHAIN HETEROARYL DERIVATIVES AS SPHINOSINE-1-PHOSPHATE RECEPTOR AGONISTS | |
| IL278045A (en) | History of pyrazo-tetrahydroisoquinoline as a dopamine D1 receptor with positive modulators | |
| IL297675B1 (en) | History of azetidine-3-ylethanol as CCR6 receptor modulators | |
| PT4200280T (pt) | Derivados de fenil-3,4-di-hidroisoquinolin-2(1h)-il-ona como moduladores alostéricos positivos do recetor d1 da dopamina | |
| IL198402A0 (en) | Allosteric modulators of the a1 adenosine receptor | |
| SG11202003284RA (en) | Heteroaryl compounds as muscarinic m1 receptor positive allosteric modulators | |
| IL307453A (en) | Opioid receptor modulators | |
| EP2242554A4 (en) | FLOW DISTRIBUTION | |
| EP2445892A4 (en) | 5-LOW HETEROARYL DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS | |
| IL204888A0 (en) | Thiophene - 2 - carboxamide derivatives as modulators of ccr9 receptor | |
| ZA201101204B (en) | Novel use application of sugar chain-recognizing receptor | |
| ZA202102487B (en) | Pyrrolo-pyridazine derivatives as muscarinic m1 receptor positive allosteric modulators | |
| EP3830083A4 (en) | ALLOSTERIC MODULATORS OF THE ?U-OPIOID RECEPTOR | |
| WO2013130501A8 (en) | Bivalent ampa receptor positive allosteric modulators | |
| HK40044338A (en) | Pyrazo-tetrahydroisoquinoline derivatives as dopamine d1 receptor positive modulators |